Assignee
ALETHIA BIOTHERAPEUTICS INC
CA·10 granted patents·7 pending applications·51 citations·filing 2005–2023
Top patents by PatentIndex Score
17 records- 0195US7989160B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2007·Granted Aug 2, 2011·25 cites·34 claims
- 0288US9067984B2Methods of impairing osteoclast differentiation using antibodies that bind Siglec-15ALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 30, 2015·6 cites·13 claims
- 0387US8900579B2Siglec-15 antibodies in treating bone loss-related diseaseALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 2, 2014·8 cites·20 claims
- 0485US9393302B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·20 claims
- 0578US9388242B2Nucleic acids encoding anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·2 cites·20 claims
- 0676US9493562B2Anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 15, 2016·3 cites·14 claims
- 0775US9040246B2Methods of making antibodies that bind polypeptides involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted May 26, 2015·1 cites·9 claims
- 0874US7947436B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2005·Granted May 24, 2011·1 cites·31 claims
- 0969US2024317884A1Method for allowing immune cells infiltration in tumorsALETHIA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1064US2024199758A1Method for allowing immune cells infiltration in tumorsALETHIA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1162US9512211B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·0 cites·8 claims
- 1261US2024207311A1Tumor infiltrating lymphocytes therapyALETHIA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2025108110A1Combination therapy for use in treatment of non-small cell lung cancerALETHIA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1452US2017233487A1Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor VolumeALETHIA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1551US2016039930A1Polynucleotides and polypeptide sequences involved in cancerALETHIA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1649US2017174753A1Method for treating breast cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1747US9822170B2Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 21, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when ALETHIA BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →